Biphenyl

Biphenyl

SCHEMBL653702

CC.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.82
SLC22A2 O15244 1/20 0.56
SLC22A1 O15245 1/20 0.56
SLC22A3 O75751 1/20 0.56
SLC6A4 P31645 1/20 0.56
TAAR1 Q96RJ0 3/20 0.53
CYP1A2 P05177 2/20 0.53
MAPK1 P28482 2/20 0.53
CYP3A4 P08684 1/20 0.53
HSD17B10 Q99714 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
NOTUM Q6P988 1/20 0.53
MMP3 P08254 1/20 0.53
BCL2L1 Q07817 1/20 0.53
SMN1; SMN2 Q16637 2/20 0.48
CYP1A1 P04798 1/20 0.48
CYP1B1 Q16678 1/20 0.48
MAPT P10636 1/20 0.48
ATM Q13315 1/20 0.47
NPC1 O15118 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL4071194 0.96 ALDH1A1 (0.75) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL9073311 0.96 ALDH1A1 (0.75) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL15952442 0.96 ALDH1A1 (0.75) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL28890607 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL2548048 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL29008551 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL4002609 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
SCHEMBL30108088 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
SCHEMBL30629023 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4
Biphenyl SCHEMBL1358618 0.91 ALDH1A1 (1.00) ALDH1A1SLC22A2SLC22A1SLC22A3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 674 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122038022-A Environment-friendly oil for power capacitor and preparation method and application thereof 南方电网科学研究院有限责任公司 2026-05-15 CN claimed
CN-119708426-A Polyurethane resin composition and application thereof 武汉尚赛光电科技有限公司 2025-03-28 CN claimed
CN-119390572-A Dichloroacetic acid coupling diphenyl ethane compound, preparation method and application thereof 上海华理生物医药股份有限公司 2025-02-07 CN claimed
US-20240350448-A1 DICHLOROACETIC ACID CONJUGATING DIPHENYL ETHANE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF SHANGHAI ECUSTBIOMEDICINECOMPANY LTD. (CN) 2024-10-24 US claimed
CN-114230466-B Dichloroacetic acid coupling diphenyl ethane compound, preparation method and application thereof 上海华理生物医药股份有限公司 2024-10-15 CN claimed
CN-118271578-A Polymer with phosphonic acid structure in side chain, synthesis method and application thereof in high-temperature proton exchange membrane fuel cell 中国科学院山西煤炭化学研究所 2024-07-02 CN claimed
CN-118165198-A Application of phosphonated hydrocarbon polymer with large steric hindrance effect as binder in high-temperature proton exchange membrane fuel cell 中国科学院山西煤炭化学研究所 2024-06-11 CN claimed
CN-117776859-B Preparation, separation and purification method of decabromodiphenyl ethane debromination product 山东科技大学 2024-05-17 CN claimed
CN-117776859-A Preparation, separation and purification method of decabromodiphenyl ethane debromination product 山东科技大学 2024-03-29 CN claimed
CN-117510802-A Anion exchange membrane containing aryl piperidine and phthalone monomer copolymer, preparation method and application 大连理工大学 2024-02-06 CN claimed
EP-0609323-A1 THERMOSENSITIVE RECORDING ELEMENT HAVING IMPROVED SMOOTHNESS CHARACTERISTICS. INT PAPER CO (US) 1994-08-10 EP claimed
EP-0563127-A1 IMPROVED TREATMENT METHOD FOR CANCER. UNIV MANITOBA (CA) 1993-10-06 EP claimed
EP-0256456-B1 PIGMENT COMPOSITION DAINICHISEIKA COLOR & CHEMICALS MFG. CO. LTD. (JP) 1993-03-10 EP claimed
WO-1992011035-A1 IMPROVED TREATMENT METHOD FOR CANCER UNIVERSITY OF MANITOBA (CA) 1992-07-09 WO claimed
EP-0472525-A1 PROCESS FOR THE PREPARATION OF STILBENE DERIVATIVES EASTMAN KODAK COMPANY (US) 1992-03-04 EP claimed
WO-1990010001-A1 PROCESS FOR THE PREPARATION OF STILBENE DERIVATIVES EASTMAN KODAK COMPANY (US) 1990-09-07 WO claimed
EP-0385890-A1 Pocess for the preparation of stilbene derivatives EASTMAN CHEMICAL COMPANY (US) 1990-09-05 EP claimed
US-4921964-A Process for the preparation of stilbene derivatives EASTMAN KODAK COMPANY (US) 1990-05-01 US claimed
US-4320034-A Electrical capacitor having an improved dielectric system MCGRAW-EDISON COMPANY (US) 1982-03-16 US claimed
EP-0003735-B1 INITIATOR MIXTURES COMPRISING ORGANIC PEROXIDES AND SUBSTITUTED DIPHENYLETHANES AND A PROCESS FOR THE STABILISATION OF ORGANIC PEROXIDES BY THE PREPARATION OF SUCH MIXTURES BAYER AG (DE) 1981-05-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240350448-A1 DICHLOROACETIC ACID CONJUGATING DIPHENYL ETHANE COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF DDT, DDC, PCCA ALDH1A1 143/4885SLC22A2 1753/4885SLC22A1 1697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.